PDCD1 and colorectal cancer: Ganoderma lucidum’s polysaccharide (GLP) has been shown to enhance antitumor immunity and boost the effectiveness of anti-PD-1 immunotherapy in colorectal cancer by increasing beneficial T-cells while decreasing immunosuppressive cells, along with improving gut microbiome health and metabolic factors.